Management updated software revenue growth guidance for 2025 to 8% to 13%, down from the previous 10% to 15%, attributing this to "the slowdown in pharma discussions resulting from the multitude of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback